Health

Reuters exclusively reports in boost for Africa, Senegal aims to make COVID shots next year

Reuters exclusively reported that Senegal could begin producing COVID-19 vaccines next year under an agreement with Belgian biotech group Univercells aimed at boosting Africa’s drug-manufacturing ambitions. The collaboration highlights the opportunities created by a global push to channel money and technology towards production on a continent that makes only 1% of the vaccines it requires. Under the agreement, the Institute Pasteur would use vaccine production technology developed by Univercells to supply COVID-19 vaccine shots to countries across West Africa.

Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Africa
Countries: Senegal
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Important Regional Story
Sign up for email updates

Subscribe
Sign up for email updates